找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Comprehensive lipid testing and management; Lars A. Carlson Book 2011 Springer Healthcare 2011 Cholestrol.Coronary heart disease.Diabetes.

[復(fù)制鏈接]
查看: 32134|回復(fù): 57
樓主
發(fā)表于 2025-3-21 16:55:39 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Comprehensive lipid testing and management
編輯Lars A. Carlson
視頻videohttp://file.papertrans.cn/232/231972/231972.mp4
概述Written by a leading and highly respected expert in the field.Concise pocket-sized format.Particularly aimed at cardiologists, clinical researchers, general practitioners, and primary care physicians.
圖書封面Titlebook: Comprehensive lipid testing and management;  Lars A. Carlson Book 2011 Springer Healthcare 2011 Cholestrol.Coronary heart disease.Diabetes.
描述Cardiovascular disease is a major cause of morbidity and mortality in developed countries. Measurement of blood of lipids and lipoproteins has become one of the most frequently performed assays in clinical chemistry laboratories, reflecting their role in the aetiology of cardiovascular disease. Pocket Reference to Comprehensive Lipid Testing and Management provides an overview of the purpose of lipid testing, diagnosis and lipid profiles as well as the goals of treatment and pharmacological management of lipid levels.The book is divided into two parts, one covering lipid testing and one covering lipid management in the prevention of cardiovascular disease.
出版日期Book 2011
關(guān)鍵詞Cholestrol; Coronary heart disease; Diabetes; Lipids; Statins
版次1
doihttps://doi.org/10.1007/978-1-908517-33-3
isbn_softcover978-1-907673-03-0
isbn_ebook978-1-908517-33-3
copyrightSpringer Healthcare 2011
The information of publication is updating

書目名稱Comprehensive lipid testing and management影響因子(影響力)




書目名稱Comprehensive lipid testing and management影響因子(影響力)學(xué)科排名




書目名稱Comprehensive lipid testing and management網(wǎng)絡(luò)公開度




書目名稱Comprehensive lipid testing and management網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Comprehensive lipid testing and management被引頻次




書目名稱Comprehensive lipid testing and management被引頻次學(xué)科排名




書目名稱Comprehensive lipid testing and management年度引用




書目名稱Comprehensive lipid testing and management年度引用學(xué)科排名




書目名稱Comprehensive lipid testing and management讀者反饋




書目名稱Comprehensive lipid testing and management讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 20:20:29 | 只看該作者
板凳
發(fā)表于 2025-3-22 02:15:22 | 只看該作者
Lipid profiless to determine LDL-C and HDL-C became available in routine clinical practice. Subsequently, attempts to advance the evaluation of risk for clinical atherosclerosis have continued, in order to improve prevention and treatment of the disease. In this respect, as described later in this chapter, two ma
地板
發(fā)表于 2025-3-22 07:22:45 | 只看該作者
Lipid testing and prediction of coronary heart diseaseerol, blood pressure, smoking and diabetes [14]. Risk prediction based on Framingham data was improved in the 1980s by addition of the ‘negative’ lipid risk factor HDL-C [15]. Subsequently, there have been further developments in risk prediction. These and the present status of risk prediction in cl
5#
發(fā)表于 2025-3-22 09:05:55 | 只看該作者
6#
發(fā)表于 2025-3-22 13:10:32 | 只看該作者
7#
發(fā)表于 2025-3-22 18:53:06 | 只看該作者
8#
發(fā)表于 2025-3-23 01:02:40 | 只看該作者
9#
發(fā)表于 2025-3-23 04:28:31 | 只看該作者
archers, general practitioners, and primary care physicians.Cardiovascular disease is a major cause of morbidity and mortality in developed countries. Measurement of blood of lipids and lipoproteins has become one of the most frequently performed assays in clinical chemistry laboratories, reflecting
10#
發(fā)表于 2025-3-23 07:12:58 | 只看該作者
https://doi.org/10.1007/978-3-8350-9259-4ausing coronary heart disease (CHD), cerebrovascular diseases and peripheral vascular diseases which here are called clinical atherosclerosis, cause considerable morbidity and disability. The major manifestations of clinical atherosclerosis are listed in Figure 1.1.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 02:06
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
永城市| 双峰县| 长顺县| 建瓯市| 抚顺县| 平谷区| 南乐县| 西宁市| 望江县| 东明县| 察雅县| 永善县| 巴马| 福贡县| 安顺市| 芦山县| 湖南省| 巴林左旗| 若羌县| 宜城市| 广灵县| 嵩明县| 镶黄旗| 鄱阳县| 娱乐| 南平市| 信宜市| 左云县| 铜陵市| 平南县| 滦平县| 宁国市| 巧家县| 平凉市| 长阳| 调兵山市| 松江区| 德昌县| 兰州市| 横山县| 昌都县|